From December 7, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on December 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
87.86 USD | +1.12% | -0.14% | +15.23% |
06-03 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
06-03 | Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.23% | 52.94B | |
+7.31% | 217B | |
+12.99% | 194B | |
+19.71% | 143B | |
+30.60% | 111B | |
+1.37% | 64.3B | |
+2.06% | 49.53B | |
-5.49% | 38.31B | |
-0.22% | 35.22B | |
+20.56% | 30.47B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on December 7, 2023.